Nijhawan Pardeep
SEC CIK 1777962 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EDSA | Edesa Biotech, Inc. | CEO, Dir, 10% | 899.1K | $321.3K | — | 56 | 2022-03-09 | 2026-09-01 |
Most active insiders at EDSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nijhawan Pardeep | CEO, Dir, 10% | $229.9K | — |
| 2 | Brooks Michael J | Pres | $3,140 | — |
| 3 | Weiler Peter J. | CFO | — | — |
| 4 | Liu Da David | Dir | — | — |
| 5 | Chypyha Joan | Dir | — | — |
| 6 | Marshall Patrick | Dir | — | — |
| 7 | MacDonald Sean Arthur | Dir | — | — |
| 8 | Sistilli Carlo | Dir | — | — |
| 9 | Olson Charles V | Dir | — | — |
Transactions 56
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-01 18:12 | 2026-09-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +5,714 | 899.1K | +0.6% | $0 | |
| 2026-08-04 17:02 | 2026-08-03 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +5,324 | 893.4K | +0.6% | $0 | |
| 2026-07-02 17:05 | 2026-07-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +3,378 | 888.1K | +0.4% | $0 | |
| 2026-06-16 17:03 | 2026-06-16 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $5.21 | +153.6K | 884.7K | +21% | +$800.0K | |
| 2026-06-01 17:00 | 2026-06-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +1,671 | 731.1K | +0.2% | $0 | |
| 2026-05-29 17:00 | 2026-05-27 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +96.9K | 729.5K | +15% | $0 | |
| 2026-05-01 21:01 | 2026-05-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +1,159 | 632.5K | +0.2% | $0 | |
| 2026-04-10 17:02 | 2026-04-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +2,578 | 631.4K | +0.4% | $0 | |
| 2026-03-10 | 2026-03-10 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $6.60 | +1,000 | 628.8K | +0.2% | +$6,600 | |
| I | 2026-03-06 | 2026-03-05 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.90 | +10.0K | 402.7K | +3% | +$39.0K |
| I | 2026-03-05 | 2026-03-04 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $4.26 | +10.0K | 392.7K | +3% | +$42.6K |
| I | 2026-03-04 | 2026-03-03 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.63 | +10.0K | 382.7K | +3% | +$36.3K |
| I | 2026-03-03 | 2026-03-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $2.28 | +1,000 | 372.7K | +0.3% | +$2,280 |
| 2026-03-03 | 2026-03-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $2.00 | +2,000 | 627.8K | +0.3% | +$4,000 | |
| 2026-03-02 | 2026-02-19 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +82.2K | 595.2K | +16% | $0 | |
| 2026-03-02 | 2026-03-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +10.0K | 625.8K | +2% | $0 | |
| 2026-03-02 | 2026-02-26 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $1.58 | +20.6K | 615.8K | +3% | +$32.5K | |
| I | 2026-03-02 | 2026-02-27 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $2.22 | +30.0K | 371.7K | +9% | +$66.6K |
| 2026-02-02 | 2026-02-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +11.2K | 513.0K | +2% | $0 | |
| 2026-01-05 | 2026-01-05 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +10.4K | 501.8K | +2% | $0 | |
| 2025-12-02 | 2025-12-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +8,766 | 491.4K | +2% | $0 | |
| 2025-11-06 | 2025-11-03 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +6,968 | 482.6K | +1% | $0 | |
| 2025-10-03 | 2025-10-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +5,908 | 475.6K | +1% | $0 | |
| 2025-09-12 | 2025-09-11 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +5,981 | 469.7K | +1% | $0 | |
| 2025-08-04 | 2025-08-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +6,802 | 463.8K | +1% | $0 | |
| 2025-07-02 | 2025-07-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +7,186 | 457.0K | +2% | $0 | |
| M | 2025-06-02 | 2025-05-29+ | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +270.8K | 449.8K | +151% | $0 |
| 2025-05-06 | 2025-05-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +6,392 | 178.9K | +4% | $0 | |
| 2025-04-03 | 2025-04-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +5,784 | 172.5K | +3% | $0 | |
| 2025-03-03 | 2025-03-03 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +6,339 | 166.7K | +4% | $0 | |
| 2025-02-04 | 2025-02-03 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +8,264 | 160.4K | +5% | $0 | |
| 2025-01-06 | 2025-01-06 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +8,476 | 152.1K | +6% | $0 | |
| 2024-12-03 | 2024-12-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +6,420 | 143.7K | +5% | $0 | |
| 2024-11-12 | 2024-11-12 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +4,630 | 137.2K | +3% | $0 | |
| 2024-10-02 | 2024-10-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +3,300 | 132.6K | +3% | $0 | |
| 2024-09-03 | 2024-09-03 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +3,055 | 129.3K | +2% | $0 | |
| 2024-08-02 | 2024-08-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +3,317 | 126.3K | +3% | $0 | |
| 2024-07-03 | 2024-07-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +4,015 | 122.9K | +3% | $0 | |
| 2024-06-04 | 2024-06-03 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +4,785 | 118.9K | +4% | $0 | |
| 2024-05-01 | 2024-05-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +3,083 | 114.1K | +3% | $0 | |
| 2024-04-02 | 2024-04-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +3,253 | 111.1K | +3% | $0 | |
| I | 2024-03-25 | 2024-03-25 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $4.00 | +5,000 | 341.7K | +1% | +$20.0K |
| 2024-03-01 | 2024-03-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +2,765 | 107.8K | +3% | $0 | |
| 2024-02-02 | 2024-02-01 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +2,978 | 105.0K | +3% | $0 | |
| 2024-01-12 | 2024-01-08 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $0.00 | +2,908 | 102.1K | +3% | $0 | |
| 2023-08-04 | 2023-08-04 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | — | +99.3K | 694.1K | +17% | — | |
| DMI | 2022-11-04 | 2022-11-02 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $1.13 | +456.5K | 228.3K | New | +$515.9K |
| 2022-05-31 | 2022-05-27 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $1.92 | +5,000 | 574.8K | +0.9% | +$9,600 | |
| 2022-05-25 | 2022-05-24 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $1.80 | +2,000 | 569.8K | +0.4% | +$3,600 | |
| 2022-03-31 | 2022-03-30 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.05 | +2,000 | 565.8K | +0.4% | +$6,100 | |
| 2022-03-30 | 2022-03-29 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.02 | +2,000 | 563.8K | +0.4% | +$6,040 | |
| 2022-03-21 | 2022-03-18 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.85 | +2,000 | 561.8K | +0.4% | +$7,700 | |
| M | 2022-03-18 | 2022-03-17 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.26 | +2,000 | 558.2K | +0.4% | +$6,516 |
| 2022-03-16 | 2022-03-15 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $2.80 | +2,000 | 557.8K | +0.4% | +$5,600 | |
| M | 2022-03-14 | 2022-03-11 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.09 | +7,000 | 555.8K | +1% | +$21.7K |
| 2022-03-10 | 2022-03-09 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.05 | +1,500 | 548.8K | +0.3% | +$4,575 |
Purchase Sale Sale after option exercise All abbreviations